CTF2P

Across TCGA pan-cancer cohorts, CTF2P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CTF2P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher CTF2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CTF2P expression acts as an unfavorable survival marker, although some lineages such as ACC and LUAD show a favorable association.

CHOL, LGG, and SKCM are the cancer types where CTF2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Quartile	All	0.153	0.598	.001	56	view →
LGG	OS	Tertile	All	0.704	0.851	<.001	50	view →
SKCM	DFS	Tertile	IV	0.082	0.549	<.001	27	view →
READ	OS	Tertile	III,IV	0.111	0.890	<.001	27	view →
ACC	OS	Tertile	II,III,IV	1.000	0.800	.006	27	view →
LUAD	DFS	Tertile	All	0.852	0.766	.014	18	view →
UCEC	DFS	Tertile	II,III,IV	0.734	0.424	.027	14	view →
KICH	OS	Quartile	III,IV	0.178	0.816	.001	10	view →
OV	OS	Quartile	All	0.760	0.661	.023	8	view →
ESCA	OS	Median	III,IV	0.538	0.320	.035	6	view →
THCA	DFS	Quartile	II,III,IV	0.840	0.947	.020	5	view →
PAAD	OS	Tertile	II,III,IV	0.491	0.617	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

CTF2P–CHOL (DFS)

Open the CHOL breakdown →